|

Iron Isomaltoside 1000 Clinical Trials

1 actively recruiting trial

Also known as: Iron isomaltoside

Pipeline

Phase 2: 1

Top Sponsors

  • Sun Yat-sen University1

Indications

  • Iron-deficiency1
  • Anemia1
  • Nasopharyngeal Carcinoma1
  • Cancer1

Other1 trial

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.